SCHEMBL18058692

SCHEMBL18058692

C[C@@H]1CC[C@H](C)[C@@H](O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL992946 1.00 — —
SCHEMBL13347079 1.00 — —
SCHEMBL15280657 1.00 — —
SCHEMBL4828480 1.00 — —
SCHEMBL19190722 1.00 — —
SCHEMBL24240089 1.00 — —
SCHEMBL13531247 1.00 — —
SCHEMBL15384524 1.00 — —
SCHEMBL22100978 1.00 — —
SCHEMBL9965214 1.00 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160256459-A1 SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE SIGNAL PHARM LLC (US) 2016-09-08 — — US disclosed
Send feedback